# Hetero USA Inc – FDA Inspection, Mar 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/hetero-usa-inc/4a8ce964-d2f9-4260-b378-f5a95d2e89f8
Source feed: FDA_Inspections

> FDA inspection 1006668 of Hetero USA Inc, March 17, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 314. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006668
- Company Name: Hetero USA Inc
- Inspection Date: 2017-03-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 735230 - 2011-07-20](https://www.keypedia.com/records/fda_inspections/hetero-usa-inc/fa759107-1217-4d87-9117-3e23ae9ffaa8)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)
- [Tonia F. Bernard](https://www.keypedia.com/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)

Company: https://www.keypedia.com/companies/hetero-usa-inc/97799f81-b657-40b2-97c6-ea8adac985a4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c